Open Access

Nintedanib: beneficial agent in post-COVID-19 Pulmonary Fibrosis

, , , , ,  and   
Jun 19, 2024

Cite
Download Cover

Țau, Victoria
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Antal, Andreea Zabară
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Doctoral School, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”Iași, Romania
Antohi, Paula Vasilache
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Stoian, Ioana Adelina
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Doctoral School, Faculty of Medicine, University of Medicine and Pharmacy “Grigore T. Popa”Iași, Romania
Pintilie, Adriana Loredana
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Trofor, Antigona Carmen
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Pulmonary Department, Faculty of General Medicine, University of Medicine and Pharmacy “Grigore T. Popa,”Iași, Romania
Crișan-Dabija, Radu Adrian
Clinical Hospital of Pulmonary Diseases IașiIasi, Romania
Pulmonary Department, Faculty of General Medicine, University of Medicine and Pharmacy “Grigore T. Popa,”Iași, Romania
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Clinical Medicine, Clinical Medicine, other, Internal Medicine, Pneumology